This HTML5 document contains 193 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://academic.oup.com/cid/article-pdf/37/9/1234/1397433/
n7http://dx.doi.org/10.1086/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11https://academic.oup.com/cid/article-pdf/37/9/1234/1397433/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44616843
rdf:type
wikibase:Item
schema:description
maqolai ilmiy научни чланак објављен 3. октобар 2003. article científic 2003年学术文章 artículo científico publicado el 3 de octubre de 2003 επιστημονικό άρθρο научная статья опубликованная 3 октября 2003 г. article scientifique publié le 3 octobre 2003 vedecký článok publikovaný 3. októbra 2003 scientific article published on October 3, 2003 научна статия, публикувана на 3 октомври 2003 г. наукова стаття, опублікована в жовтні 2003 znanstveni članek objavljen 3. oktober 2003 artikulong pang-agham artikel ilmiah научни чланак објављен 3. октобар 2003. 2003年學術文章 articol științific 2003년 논문 tudományos cikk სამეცნიერო სტატია vědecký článek publikovaný 3. října 2003 artigo científico publicado em 3 de outubro de 2003 naučni članak 2003年學術文章 2003年の学術論文 บทความทางวิทยาศาสตร์ im 3. Oktober 2003 veröffentlichter wissenschaftlicher Artikel teaduslik artikkel artykuł naukowy opublikowany 3 października 2003 مقالة علمية نشرت في 3 أكتوبر 2003 vitenskapelig artikkel 2003年学术文章 2003年学术文章 article scientific мақолаи илмӣ scientific article published on 3 October 2003 bài báo khoa học xuất bản ngày 3 tháng 10, 2003 videnskabelig artikel offentliggjort den 3. oktober 2003 vitskapeleg artikkel artikull shkencor i botuar më 3 tetor 2003 2003 nî ê lūn-bûn vetenskaplig artikel publicerad den 3 oktober 2003 מאמר מדעי 2003年學術文章 2003 թվականի հոկտեմբերի 3-ին հրատարակված գիտական հոդված artigo científico publicado em 3 de outubro de 2003 2003年學術文章 scienca artikolo mokslinis straipsnis, publikuotas 2003 m. spalio 3 d. 2003年学术文章 tieteellinen artikkeli wetenschappelijk artikel gepubliceerd op 3 oktober 2003 artigo científico 2003年学术文章 artículu científicu espublizáu en 2003 2003年學術文章 3 Ekim 2003'de yayımlanmış bilimsel makale articolo scientifico pubblicato il 3 ottobre 2003 scientific article published on 3 October 2003 2003年学术文章 ৩ অক্টোবর ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ
p:P577
wds:Q44616843-561D39D5-E8F8-4CAA-941C-2075EF4E15F0
wdt:P577
2003-10-03T00:00:00Z
p:P407
wds:Q44616843-6BDB76FF-4A14-4987-BDFC-B3B823B91E1C
wdt:P407
wd:Q1860
p:P2860
wds:Q44616843-FB7D86E1-FA13-467B-9798-9864BC7A79F7 wds:Q44616843-C8191BDE-B2F3-45D5-A792-BF4C4D23AB0A wds:Q44616843-CC7CB6A3-95D3-481A-B410-374BB7507623 wds:Q44616843-CD806F0D-E0D2-4902-B0A1-BA16D18164B1 wds:Q44616843-D57893EB-B4E2-4367-884C-E6D562FFC030 wds:Q44616843-1D0A46B6-E4F3-40F1-933B-4EBB91852BF6 wds:Q44616843-27DC1BD3-BD69-4FE2-A3D8-59C2E5ECF836 wds:Q44616843-30B454BE-9496-4A1A-B06D-E004E34D04D0 wds:Q44616843-03C85685-C534-4EDA-BF05-0942AE76E6A0 wds:Q44616843-1B0BBC92-9CBD-40B2-BC07-8AE2195454D7 wds:Q44616843-A75754DE-903F-4623-BA6B-0F627FDF6D21 wds:Q44616843-AC2E7A7F-CFF9-4A97-A6D2-63F5CD22C284 wds:Q44616843-B159AC17-9BCA-47F9-8BFD-7EF0E40F4CC0 wds:Q44616843-BD4FB824-2EBD-4CA9-A23A-E5B029D936D6 wds:Q44616843-7EF0A6B3-DD50-4092-A6A5-15BCCA5630D5 wds:Q44616843-8FF8591B-A5F1-4CF6-8296-4B1D422B5A38 wds:Q44616843-9285034D-C65D-44A1-B254-1F9C73AB49EF wds:Q44616843-94B525C0-5392-46DD-AB30-F5457C75DBE2 wds:Q44616843-5B94ABCD-AA11-48B6-9676-6BA25C257C4A wds:Q44616843-648B069A-8CB0-49B6-85C3-6258B5213BF7 wds:Q44616843-72416334-06D9-405F-AC5B-CFE96679E855 wds:Q44616843-75ABE50F-B49E-4664-8C7A-02205742ABF8 wds:Q44616843-433A145D-B2FA-4BFE-98D5-DF6A20703300 wds:Q44616843-4457615E-7666-405C-A34D-98470448F6C6 wds:Q44616843-E9B4083E-45DF-4E83-BB5B-5ADEC347428D wds:Q44616843-F06D4A1F-A92A-4E4A-A488-D10FABEAB5D3
wdt:P2860
wd:Q29547281 wd:Q34750943 wd:Q33915548 wd:Q40646172 wd:Q44359890 wd:Q60343134 wd:Q28184540 wd:Q40702030 wd:Q58321752 wd:Q46357077 wd:Q40654275 wd:Q72852761 wd:Q33691292 wd:Q58321680 wd:Q37133132 wd:Q40938509 wd:Q46195226 wd:Q45739770 wd:Q28369301 wd:Q72896180 wd:Q45938185 wd:Q44912769 wd:Q28362689 wd:Q36247045 wd:Q58416454 wd:Q72022258
p:P2093
wds:Q44616843-F4A00537-7EEA-437D-8468-6535467C8856 wds:Q44616843-D1B601C1-F29F-4D56-BE2D-CA6B5C959054 wds:Q44616843-C9A67651-78D0-4ACA-A685-F40BB10702BF wds:Q44616843-3F93B9AA-BF4A-4E46-BFEE-961DD0033B5F wds:Q44616843-373781E8-A5C6-4D68-A111-996236645A50 wds:Q44616843-C009A619-1508-4FDF-A652-DB066210AF4B wds:Q44616843-9F7A6DA0-C8C8-4113-B9A1-5558D62726ED wds:Q44616843-9089ECB1-A363-425D-B172-5984A4885D7A wds:Q44616843-7FFAA488-F2C4-4429-8B8F-92DF9624A169 wds:Q44616843-26231DE7-34DC-4DEA-A143-849F1E0A0A8C wds:Q44616843-1C273302-A4D9-4A5B-B18E-547A1136FE77 wds:Q44616843-0E799945-0B4E-47F2-A00F-C3554AD1A9DB
wdt:P2093
Gerard F. Notario Rob Roy MacGregor Fiona Holland Constance A. Benson Richard Chaisson Judith Neidig Richard Hafner Clark B. Inderlied AIDS Clinical Trials Group 223 Protocol Team Judith S. Currier Charles Flexner Laura F. Mahon
rdfs:label
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy
skos:prefLabel
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy
schema:name
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy
p:P50
wds:Q44616843-2FA1D17D-6062-420E-9E48-13130DFECDCD wds:Q44616843-C1D9800F-EE04-4BC4-A11B-E6677704FB1F
wdt:P50
wd:Q92245374 wd:Q77050292
p:P1476
wds:Q44616843-B3A8E724-4B9D-4DFC-A911-8B1BED21DBEE wds:Q44616843-312DC28E-5412-4152-BB96-F6D7BAE60840
wdt:P1476
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency sy A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
p:P304
wds:Q44616843-CFC334E7-8E07-44AD-A3D3-F7A34B26603F
wdt:P304
1234-1243
p:P31
wds:Q44616843-9235733E-A736-4C0A-A71D-4405B8B71398
wdt:P31
wd:Q13442814
p:P2283
wds:Q44616843-358F7078-D2E2-430B-8AD8-FC5E24603D89
wdt:P2283
wd:Q1231081
p:P921
wds:Q44616843-3CE4F28B-7EAB-47AA-86BC-BEB86778237D wds:Q44616843-54D3B6C8-7DD4-4306-8DCA-D998EDA50E9E wds:Q44616843-12CFB13B-6557-4039-9B3A-2CD2C91B6705 wds:Q44616843-08FDF178-C76C-42A2-9EFB-77042D8D8C43 wds:Q44616843-2CAA9BF8-2E1E-4786-B874-3BB5BFF9093B
wdt:P921
wd:Q118551 wd:Q1135705 wd:Q1231081 wd:Q310728 wd:Q412318
p:P698
wds:Q44616843-8BC4FA68-E78F-43D0-9F0D-EC82735441CE
wdtn:P698
n13:14557969
wdt:P698
14557969
p:P1433
wds:Q44616843-697D8039-A620-417C-B9E6-16D0F5F56BD1
p:P953
wds:Q44616843-2772562A-CBAC-4AE6-B499-5C504A48B048 wds:Q44616843-FF46BABE-1891-4F42-8D70-2184E7FBA85B
wdt:P1433
wd:Q5133764
wdt:P953
n11:37-9-1234.pdf n12:37-9-1234.pdf
p:P433
wds:Q44616843-3D6F7B59-C9D1-4D51-A1C2-B89C63E9472C
p:P478
wds:Q44616843-4B06DADB-8DE7-4EF5-8147-515536EC9F12
wdt:P433
9
wdt:P478
37
p:P356
wds:Q44616843-09293018-031A-4E8A-AF32-0E3F7411DC7D
wdtn:P356
n7:378807
wdt:P356
10.1086/378807
p:P8608
wds:Q44616843-00D2C314-65F7-4C07-85F4-E84C6B345459
wdt:P8608
release_sabuvzayd5co5nr2urnw3on7sy
p:P5875
wds:Q44616843-D4A4F44C-7B9E-4008-A251-4A8BAE44387A
wdt:P5875
9051950